Therapeutic and Pharmaceutical Applications of Pegylated Nano-Carriers
| dc.contributor.author | Shakeri, R. | |
| dc.contributor.author | Mirjalili, S.Z. | |
| dc.contributor.author | Karakus, C.O. | |
| dc.contributor.author | Safavi, M. | |
| dc.date.accessioned | 2025-06-26T20:20:30Z | |
| dc.date.available | 2025-06-26T20:20:30Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | The coating of the exterior of nanocarriers with polyethylene glycol (PEG; known as “PEGylation”), has emerged as one of the most widely adopted approaches to impart stealth properties to pharmaceutical nanocarrier systems. The PEGylation tactic offers a stealth barrier towards the adsorption of circulatory proteins owing to its hydrophilicity, elasticity, neutralization, and hydration properties. PEGylation dramatically provides sustained drug release benefits, reduces immune sensitivity, as well as improves the systemic circulation period, Overall, PEGylation effectively improves the therapeutic efficacy of the loaded therapeutic moiety in treating target cells and tissues. This chapter offers discussion on drug delivery nanosystems that are developed based on the principle of PEGylation strategy. Furthermore, a detailed account of the pharmaceutical and biomedical applications of PEGylated nanocarriers has also been presented in detail. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2024. | en_US |
| dc.identifier.doi | 10.1007/978-981-97-7316-9_18 | |
| dc.identifier.isbn | 9789819773169 | |
| dc.identifier.isbn | 9789819773152 | |
| dc.identifier.scopus | 2-s2.0-105007409800 | |
| dc.identifier.uri | https://doi.org/10.1007/978-981-97-7316-9_18 | |
| dc.identifier.uri | https://hdl.handle.net/11147/15686 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer Nature | en_US |
| dc.relation.ispartof | PEGylated Nanocarriers in Medicine and Pharmacy | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Immunosensitivity | en_US |
| dc.subject | Pharmaceutical Applications | en_US |
| dc.subject | Stealth Properties | en_US |
| dc.subject | Therapeutic Benefits | en_US |
| dc.title | Therapeutic and Pharmaceutical Applications of Pegylated Nano-Carriers | en_US |
| dc.type | Book Part | en_US |
| dspace.entity.type | Publication | |
| gdc.author.scopusid | 55932020200 | |
| gdc.author.scopusid | 57218911376 | |
| gdc.author.scopusid | 58882532000 | |
| gdc.author.scopusid | 25227167300 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::book::book part | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Institute of Technology | en_US |
| gdc.description.departmenttemp | [Shakeri R.] Faculty of Science, Department of Biological Science, University of Kurdistan, Sanandaj, Iran; [Mirjalili S.Z.] Faculty of Pharmacy, Drug and Food Control Department, Tehran University of Medical Sciences, Tehran, Iran; [Karakus C.O.] Department of Bioengineering, Izmir Institute of Technology, Izmir, Turkey; [Safavi M.] Department of Biotechnology, Iranian Research Organization for Science and Technology, Tehran, Iran | en_US |
| gdc.description.endpage | 602 | en_US |
| gdc.description.publicationcategory | Kitap Bölümü - Uluslararası | en_US |
| gdc.description.startpage | 555 | en_US |
| gdc.identifier.openalex | W4408069809 | |
| gdc.index.type | Scopus | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 0.0 | |
| gdc.oaire.influence | 2.635068E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.popularity | 2.1091297E-10 | |
| gdc.oaire.publicfunded | false | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 0.0 | |
| gdc.openalex.normalizedpercentile | 0.11 | |
| gdc.openalex.toppercent | TOP 10% | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.mendeley | 5 | |
| gdc.plumx.scopuscites | 0 | |
| gdc.scopus.citedcount | 0 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9af2b05f-28ac-4003-8abe-a4dfe192da5e |
